Top Back to top

JACIE Activity Report 2024

JACIE continued to work towards its goal – to harmonise and continually improve quality control standards in cellular therapy in Europe and beyond. In this, JACIE has continued to make strides in increasing its reach and activity with a record number of inspections carried out in 2024. This is thanks to the nearly 300 inspectors and the committee members, who have given their time generously to the benefit of the Cellular Therapy community. 

There is still a lot to do. JACIE will continue the development of the 9th Edition of HCT and the 3rd Edition of IEC Standards in collaboration with the colleagues from FACT.  We also know that the advancements in cellular therapies and new technologies promise a dynamic future for JACIE as we strive to build a stronger, more inclusive community.

Activity update

JACIE’s activity continued a strong post-covid performance. There were 99 applications in 2024, with 11% of the centres applying for initial accreditation and 9% applying for their 4th re-accreditation. Although JACIE remains firmly embedded in the European Cellular Therapy community, there is an increasing interest in JACIE in Middle East and further afield accounting currently approximately 5% of the applications. 

JACIE carried out 91 inspections in 2024, which is the highest number of inspections in the history of JACIE (2023: 77 inspections). This is only possible thanks to the commitment of our inspectors; many of whom have carried out two or even three inspections in the course of the year. 

There was a slight increase in the number of centres accredited in 2024 with 72 Centres completing the process in 2024.  This reflects the collaborative efforts of the Accreditation Committee, which continued to meet fortnightly to review all the inspection reports, and the applicants responding in a timely manner to deficiencies identified during the inspections.

 

 

Institutions accredited in 2024

FacilityInstitutionCityCountry
Centro Trapianti di Cellule Staminali Emopoietiche Reggio EmiliaAUSL di Reggio Emilia-IRCCSReggio EmiliaItaly
Cellular and Molecular Therapies (CMT), NHS Blood and Transplant, SouthamptonNHS Blood and TransplantSouthamptonUnited Kingdom
Programme de greffe de CSH_Hématologie clinique - HémobiothérapieHôpital Pitié-Salpêtrière APHP Sorbonne Université DMU ORPHéParisFrance
The autologous hematopoietic stem cell transplantation program for Department of Hematology and Department of Clinical ImmunologyOdense University HospitalOdenseDenmark
Programma Trapianto ASST  Valle OlonaASST Valle Olona Bursto ArsizioBusto ArsizioItaly
Seracell Pharma GmbH​ Cell processing-minimally manipulatedSeracell Pharma GmbHRostockGermany
Manchester Royal Infirmary Adult Haematology Stem Cell, Cellular & Gene Therapies UnitManchester University NHS Foundation TrustManchesterUnited Kingdom
St Vincent’s Hospital BMT ProgramThe Kinghorn Cancer Centre, St Vincent’s HospitalSydneyAustralia
University Hospitals Bristol and Weston NHS Foundation Trust Stem Cell Transplant and Cellular Therapy ProgrammeUniversity Hospitals Bristol NHS Foundation TrustBristolUnited Kingdom
King’s College Hospital NHS Foundation Trust - Department of Haematological MedicineNHS Foundation TrustLondonUnited Kingdom
South West Peninsula Transplant ServiceUniversity Hospitals Plymouth NHS Trust, Plymouth, and Royal Cornwall Hospitals NHS Trust, TruroPlymouthUnited Kingdom
HSTP- GZAGZA hospitals campus Sint AugustinusWilrijkBelgium
Programma TrapiantoIstituto Nazionale Tumori Fondazione G.PascaleNapoliItaly
Gloucestershire Haematopoietic Stem Cell Transplant ServiceGloucestershire Hospitals NHS Foundation TrustCheltenhamUnited Kingdom
Zentrum für Stammzell- und immunologische Zelltherapie (ZSIZ)Klinik für Hämatologie, Onkologie, Stammzelltransplantation und Zelltherapie Universitätsklinikum Knappschaftskrankenhaus BochumBochumGermany
Programma Trapianto CSEAzienda Ospedaliero-Universitaria di ModenaModenaItaly
UHL HPC Transplant Programme Leicester Royal Infirmary, University Hospital of Leicester NHS Trust (UHL) and Northampton General Hospital NHS Trust (NGH)Leicester Royal InfirmaryLeicesterUnited Kingdom
Klinik I für Innere Medizin and Pädiatrische Onkologie und HämatologieUniversitätsklinikum Köln (AöR)CologneGermany
​​​MEDYAG Kft.MEDYAG Kft.DebrecenHungary
BMT and CART programmeGreat Ormond Street Hospital for Children NHS Foundation TrustLondonUnited Kingdom
Kliniken Essen-Mitte || Klinik für Hämatologie | Int. Onkologie | StammzelltransplantationEvangelisches Krankenhaus Essen-WerdenEssenGermany
Paediatric Hematopoietic Stem Cell Transplantation Unit & Immune Effector Cell (CAR-T) paediatric UnitHospital Sant Joan de DéuEsplugues de LlobregatSpain
Center of Oncology/Hematology and Transfusion Medicine, Kantonsspital Aarau, SwitzerlandKantonsspital Aarau AGAarauSwitzerland
Programme de transplantation de cellules souches hématopoïétiques adulte et pédiatriqueCliniques Universitaires Saint-Luc (CUSL)BrusselsBelgium
BST - Hospital Dr. Josep Trueta GironaBanc de Sang i TeixitsGironaSpain
BST - Hospitalet de Llobregat-BellvitgeBanc de Sang i TeixitsHospitalet de LlobregatSpain
BST - Hospital Sant Joan de DéuBanc de Sang i TeixitsEsplugues de LlobregatSpain
BST - Hospital Germans Trias i PujolBanc de Sang i TeixitsBadalonaSpain
BST - Hospital Sant PauBanc de Sang i TeixitsBarcelonaSpain
Stem Cell Transplantation/ IEC Programme University Medical Centre Utrecht and Sanquin (including Wilhelmina Children’s Hospital WKZ - Princess Máxima Center for pediatric oncology joint programme)University Medical Center Utrecht Sanquin Princess Máxima CenterUtrechtNetherlands
Service des Maladies du SangCHU Angers & EFS CPDLAngersFrance
Wessex Blood and Marrow Transplant & Cellular TherapyUniversity Hospital Southampton NHS Foundation Trust
incorporating: 
Portsmouth University Hospitals NHS Trust 
Salisbury District Hospital NHS Foundation Trust
SouthamptonUnited Kingdom
CMT Cellex Manufacturing Transports and Logistics GmbHCMT Cellex Manufacturing Transports and Logistics GmbHCologneGermany
Programma Trapianti Cellule Staminali periferiche e midollari AST-PU (Azienda Sanitaria Territoriale Pesaro Urbino)Azienda Sanitaria Territoriale Pesaro UrbinoPesaroItaly
Centrum voor Oncologie, Autoloogstamceltransplantatie programmaAZ Turnhout vzw, Campus Sint-ElisabethTurnhoutBelgium
University Medical Centre Wuerzburg, Institute for Clinical 
Transfusion Medicine and Hemotherapy (IKTH), Apheresis Collection and Cell Processing Program
Institute for Clinical Transfusion Medicine an Hemotherapy (IKTH), Universitätsklinik WürzburgWürzburgGermany
Centro Trapianto AdultiOspedale San GerardoMonzaItaly
NHS Blood and Transplant- Therapeutic Apheresis Services SheffieldNHS Blood and Transplant, Therapeutic Apheresis ServicesSheffieldUnited Kingdom
Transplant programme at 4th Department of Internal Medicine – Hematology, University Hospital Hradec KrálovéUniversity Hospital Hradec KrálovéHradec KrálovéCzech Republic
Unité d’Hématologie Oncologie Pédiatrique - Hôpital des enfantsCHU de BordeauxBordeauxFrance
Programa de TPHHospital Universitario de NavarraPamplonaSpain
CHU de Grenoble AlpesCHU de Grenoble AlpesLa TroncheFrance
Paediatric BMT CenterEge University Medical SchoolİzmirTurkey
Aarhus Center for Hematopoietic Stem Cell TransplantationAarhus University HospitalAarhusDenmark
Hämatologie, Onkologie und Palliativmedizin und Bereich Blutprodukte – StammzellherstellungRobert Bosch KrankenhausStuttgartGermany
Programa de Trasplante de Progenitores Hematopoyéticos del Hospital Clínic de BarcelonaHospital clinic de BarcelonaBarcelonaSpain
Programme de Greffe de Moelle du CHU de NantesCHU de NantesNantesFrance
Autologous Stem Cell ServiceGreat Western Hospitals NHS Foundation TrustSwindonUnited Kingdom
Unidad de Trasplante HematopoyéticoComplejo Hospitalario Universitario de A CoruñaA CoruñaSpain
 Hospital Universitario Central de AsturiasOviedoSpain
Programma di Trapianto Autologo di Midollo Osseo (P-TMO autologo)Istituto Oncologico Veneto-IRCSSPadovaItaly
Medizinische Klinik mit Schwerpunkt Hämatologie, Onkologie und TumorimmunologieCharité Universitätsmedizin BerlinBerlinGermany
Hematopoietic stem cell transplantation programAntwerp University Hospital (UZA)EdegemBelgium
Programa de Trasplante y Terapia CelularComplexo Hospitalario Universitario de VigoVigoSpain
The Norwegian Stem Cell Transplantation Program.Haukeland University HospitalBergenNorway
The South African National Blood Services Haematopoietic Cellular Therapy Collections and Processing FacilitiesThe South African National Blood ServicesJohannesburgSouth Africa
 Hospital Clínico Universitario de ValenciaValenciaSpain
The Stem Cell Transplantation and Cellular Therapy UnitThe Clatterbridge Cancer Centre NHS Foundation TrustLiverpoolUnited Kingdom
Bone Marrow Transplantation UnitUniversity Hospital of PatrasRio PatrasGreece
Haematopoietic Stem Cell Transplant Unit, Aberdeen Royal InfirmaryNHS GrampianAberdeenScotland
Programma Trapianti Dipartimento OncologicoLa Maddalena S.p.A.PalermoItaly
UOC EmatologiaASST Papa Giovanni XXIII – Hematology and Bone Marrow Transplant UnitBergamoItaly
Programa de Trasplante y Terapia CelularInstitut Català d´Oncologia, Hospital Duran i ReynalsL'Hospitalet de LlobregatSpain
Marien Kliniken Department of Hematology, Oncology and Stem Cell TransplantationMarien Gesellschaft Siegen gGmbHSiegenGermany
AO San Camillo Forlanini, UOC EMATOLOGIA E TRAPIANTI CELLULE STAMINALIAO San Camillo ForlaniniRomeItaly
Department of HaematooncologyUniversity Hospital OstravaOstravaCzech Republic
Stem Cell Transplantation Unit, Department of HematologyHelsinki University Hospital Comprehensive Cancer CenterHelsinkiFinland
Centro Unico Trapianti di CSE Adulti e PediatricoARNAS G.BrotzuCagliariItaly
 Fondazione IRCCS Policlinico San MatteoPaviaItaly
Department of Medicine II, Sektion Stammzell-TransplantationUniversitäts-Klinikum AugsburgAugsburgGermany
Department of TransplantationUniversity Children's Hospital of KrakowKrakowPoland
Programme lausannois de transplantation de CSH autologues CHUV | Centre hospitalier universitaire vaudoisLausanneSwitzerland

JACIE Inspectors

In 2024, three Inspector Training Courses took place in Barcelona, Cambridge and Stockholm with a total of 59 new inspectors trained. The training days are always highlights in the JACIE calendar and we would like to thank BSBMTCT JACIE Committee and the Nordic Transplant Group for their support for these training events. 

JACIE continued the grants programme to the inspectors to attend the 50th Annual Meeting of the EBMT in Glasgow, enabling valuable opportunities for learning and collaboration. A total of 72 grants were awarded to attend the meeting either in-person or virtually. Additionally, as part of JACIE’s commitment to enhance inspector incentives, the Per Diem for inspections was increased from €80/day to €120/day to ensure that the inspectors will not incur any expenses during the inspection visits. Lastly, the Inspector Committee (JIC) continued to lead Inspectors' Webinars providing regular updates both on the Standards and accreditation process to the inspectors. 

JIC is an important stakeholder committee representing the Inspectors, a key stakeholder group in the accreditation process. Following an open call for Expressions of Interest, the Inspector Committee welcomed new members as well as a new Chair as Ms Eugenia Trigoso stepped down as the Chair after two busy and successful years in the lead.

9th Edition Standards review process

JACIE continued in 2024 the collaboration with FACT (Foundation for Accreditation in Cellular Therapy) to develop the 9th edition of the HSC Standards and the 3rd edition of the Immune Effector Cells (IEC) Standards

FACT-JACIE Steering Committee met in San Antonio, Texas, USA in February to review the drafts developed in the Sub-Committees for Clinical, Collection, Processing and Quality Management Standards. After further review by the sub-committees, the Standards were open for Public consultation the 3rd quarter of 2024. The Sub-Committees  will review the comments received and the prepare the final version for publication in the course of 2025. 

JACIE Centres

JACIE is committed to supporting Centres interested in any of the stages of the accreditation process. This work is led by the Quality Managers Committee (QMC). The Committee welcomed new members in 2024 and also said a fond farewell to Mrs Renza Monteleone whose leadership has been vital in developing the Quality Management days in the EBMT Annual Meetings.   

Following the successful introduction of the E-learning programme for Centres end of 2023, JACIE introduced quarterly Drop-in Sessions for Centres. These sessions are designed for both Centres beginning their JACIE journey and those already in the process. They provide a valuable opportunity to connect directly with the JACIE team, gain insights, and have questions about the Accreditation process answered. 

Finally,  JACIE made a transition from paper certificates to digital certificates in 2024. These certificates are now provided in a safe, digital format and can also be verified online for added convenience and security. For Centres that prefer a physical copy, the digital certificates can be easily downloaded as high-resolution PDFs for printing. This shift not only streamlines processes but also aligns with our commitment to reducing environmental impact.